Crown Resorts Ltd sues NSW as the group of powerful adversaries touched the sightlines of Sydney Resorts

Crown-Melbourne - Kalkine Media

Australian casino giant Crown Resorts Ltd (ASX: CWN) filed a lawsuit to stop Government of New South Wales from giving consent to the developments that obstruct views of Sydney Opera House and Harbour Bridge from its new Sydney resort. The group’s move is against Barangaroo Delivery Authority as it is looking to have an order basis the contract that indicates that CWN will be consulted on any development that has the potential of impacting the sight from Central Barangaroo development.

The Crown’s sightlines obstruction occurred ahead of the six-hectare site development next door which is assumed to be backed by two of the country’s richest families and Chinese billionaire as per the reliable sources.

Thus, this whole move resorts to the contract obligation and is indicative of some kind of negotiation needed in terms of adherence to the contract basis that the sightlines from the Harbour Bridge to the Sydney Opera House are with Crown Sydney Hotel Resort.

In reply to contractual obligations questioned by casino giant, a spokesperson from Barangaroo Development Authority stated that it has been negotiating with Crown and Lendlease about their sightlines for 28 months. He also added authority has always acted in accordance with the contract.

As investors remain unaffected to the above update, CWN shares price rocketed by 6.682% to $14.210, building to the annual results announcement for FY18. On August 10, 2018, the stock inched up to $14.26 by 1:00 PM AEST.

Dividend Stocks To Buy

Sponsored ad by Kalkine

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here